Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

A Kontush, MJ Chapman - Pharmacological reviews, 2006 - ASPET
High-density lipoproteins (HDL) possess key atheroprotective biological properties,
including cellular cholesterol efflux capacity, and anti-oxidative and anti-inflammatory …
被引用次数：996 相关文章

[引用][C] Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

A Kontush, MJ Chapman - Pharmacological Reviews, 2006 - cir.nii.ac.jp
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads
of Dyslipidemia, Inflammation, and Atherosclerosis | CiNii Research CiNii 国立情報学研究所 …
[PDF] researchgate.net

[PDF][PDF] Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

A KONTUSH, MJ CHAPMAN - PHARMACOLOGICAL REVIEWS, 2006 - researchgate.net
High-density lipoproteins (HDL) pos-sess key atheroprotective biological properties,
including cellular cholesterol efflux capacity, and antioxidative and anti-inflammatory …
[PDF] academia.edu

[PDF][PDF] Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

A KONTUSH, MJ CHAPMAN - PHARMACOLOGICAL REVIEWS, 2006 - academia.edu
High-density lipoproteins (HDL) pos-sess key atheroprotective biological properties,
including cellular cholesterol efflux capacity, and antioxidative and anti-inflammatory …

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.

A Kontush, MJ Chapman - Pharmacological Reviews, 2006 - europepmc.org
High-density lipoproteins (HDL) possess key atheroprotective biological properties,
including cellular cholesterol efflux capacity, and anti-oxidative and anti-inflammatory …

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

A Kontush, MJ Chapman - Pharmacological reviews, 2006 - pubmed.ncbi.nlm.nih.gov
High-density lipoproteins (HDL) possess key atheroprotective biological properties,
including cellular cholesterol efflux capacity, and anti-oxidative and anti-inflammatory …

[引用][C] Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

A KONTUSH - Pharmacol Rev, 2006 - cir.nii.ac.jp
Functionally defective high-density lipoprotein : a new therapeutic target at the crossroads of
dyslipidemia, inflammation, and atherosclerosis | CiNii Research CiNii 国立情報学研究所 学術 …
[PDF] researchgate.net

[PDF][PDF] Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

A KONTUSH, MJ CHAPMAN - PHARMACOLOGICAL REVIEWS, 2006 - researchgate.net
High-density lipoproteins (HDL) pos-sess key atheroprotective biological properties,
including cellular cholesterol efflux capacity, and antioxidative and anti-inflammatory …

[引用][C] Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

A KONTUSH, MJ CHAPMAN - …, 2006 - American Society for Pharmacology …